Research map: Impact of Gleason Grade at the Positive Surgical Margin on Biochemical Recurrence After Radical Prostatectomy in pT2N0 Prostate Cancer

Back to the article

Papers in this map

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent · Philip A Cornford · 2024 · 1253 citations · Cited by this paper
  2. Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies · 2026 · Related
  3. Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial · Ian Murchie Thompson · 2009 · 1233 citations · Cited by this paper
  4. The Utility of the Comprehensive Complication Index in Demonstrating the Complication Burden and Predicting Length of Stay in Robot-Assisted Radical Prostatectomy · 2026 · Related
  5. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) · M. Bolla · 2012 · 873 citations · Cited by this paper
  6. Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation · 2026 · Related
  7. DO MARGINS MATTER? THE PROGNOSTIC SIGNIFICANCE OF POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY SPECIMENS · Peter Swindle · 2005 · 449 citations · Cited by this paper
  8. Exploration of the Challenges in the Management of Prostate Cancer in East Africa · 2025 · Related
  9. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial · Andrew B. Kneebone · 2020 · 378 citations · Cited by this paper
  10. Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study · 2026 · Related
  11. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer · Derya Tilki · 2024 · 354 citations · Cited by this paper
  12. Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review · 2026 · Related
  13. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial · Paul Sargos · 2020 · 336 citations · Cited by this paper
  14. Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT) · 2026 · Related
  15. Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy · Ofer Yossepowitch · 2007 · 193 citations · Cited by this paper
  16. Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis · 2026 · Related
  17. The Impact of Solitary and Multiple Positive Surgical Margins on Hard Clinical End Points in 1712 Adjuvant Treatment–Naive pT2–4 N0 Radical Prostatectomy Patients · Julian Mauermann · 2012 · 99 citations · Cited by this paper
  18. A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer · 2025 · Related
  19. Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer · Alberto Martini · 2019 · 87 citations · Cited by this paper
  20. Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules · 2025 · Related
  21. Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis · Athul John · 2023 · 44 citations · Cited by this paper
  22. Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis · Ivan Lysenko · 2020 · 38 citations · Cited by this paper
  23. Prognostic Value of Focal Positive Surgical Margins After Radical Prostatectomy · Sangchul Lee · 2015 · 35 citations · Cited by this paper
  24. Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan‐confined prostate cancer · Felix Preißer · 2022 · 18 citations · Cited by this paper
  25. Contemporary methods for surgical margin assessment in radical prostatectomy: a systematic review and meta-analysis of diagnostic test accuracy · Josep M. GAYA · 2026 · 1 citation · Cited by this paper
  26. Total Positive Margin Length as a Novel Prognostic Indicator After Radical Prostatectomy · Takafumi Hibino · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)